Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (16780)	3/8/1998 7:22:00 AM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

Torben, I don't expect readers of this board to have a full grasp of the Ligand science, read the articles, or even read the abstracts. However, most of the posts this weekend have been in the STATs area. They center around recent presentations and a future publication. Although I didn't have a full set of info on exactly when the publication might come out, I did say that it would be a big deal and would be proceeded by a press release. To think that it already has come out without fan fare and had been done by a group distantly affiliated with Ligand (the earlier paper at least had the clinician as a co-author), is really not paying attention. You have enough background to recognize that a report out of SKI dealing with APL might have some significance to LGND. I'm afraid that others are totally clueless.